Literature DB >> 3023626

A recombinant Chinese hamster ovary cell line containing a 300-fold amplified tetramer of the hepatitis B genome together with a double selection marker expresses high levels of viral protein.

F A Asselbergs, H Will, P Wingfield, M Hirschi.   

Abstract

A new series of double-selection plasmids containing recombinant genes expressing the neomycin phosphotransferase (NEO) of transposon Tn5 and mouse dihydrofolate reductase (DHFR) in mammalian cells is described. Activity of the recombinant DHFR gene varied more than 50-fold, depending on the location of the simian virus 40 72 base-pair repeat or enhancer, which is part of the promoter of the NEO unit. A NEO-DHFR module with the enhancer located at the 3' end of the DHFR gene was inserted into a plasmid containing four tandem head-to-tail copies of the hepatitis B virus (HBV) genome and the new plasmid was used to transform DHFR- Chinese hamster ovary cells. In one of the cell lines obtained, an unrearranged copy of the HBV tetramer could be amplified 300-fold by increasing selective pressure with methotrexate, resulting in a proportional increase of the synthesis of HBV surface antigen. Four different mRNAs detected in the amplified cell line probably encode HBV core protein, pre-S and surface antigens, and the X protein. As a result of the DNA amplification, synthesis of HBV proteins is no longer restricted to resting cells. Integrated plasmid sequences appear to be stable during the amplification process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023626     DOI: 10.1016/0022-2836(86)90312-8

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Shuttle vectors conferring hygromycin B resistance to E. coli and to mammalian cells. Differential expression of carboxyterminal fusion proteins.

Authors:  F A Asselbergs; R Pronk
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

2.  Increased susceptibility of transfected prokaryotic and eukaryotic cells to antibiotic selection.

Authors:  F A Asselbergs; P van Someren
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

3.  X-region-specific transcript in mammalian hepatitis B virus-infected liver.

Authors:  S Kaneko; R H Miller
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  High-level expression of a cDNA for human granulocyte colony-stimulating factor in Chinese hamster ovary cells. Effect of 3'-noncoding sequences.

Authors:  L Rotondaro; L Mazzanti; A Mele; G Rovera
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.695

5.  Binding site for IgE of the human lymphocyte low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is confined to the domain homologous with animal lectins.

Authors:  B Bettler; R Maier; D Rüegg; H Hofstetter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Stable expression of antibiotic resistance genes using a promoter fragment of the U1 snRNA gene.

Authors:  F A Asselbergs; R Pronk
Journal:  Mol Biol Rep       Date:  1993-02       Impact factor: 2.316

7.  The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation.

Authors:  H J Schlicht; J Salfeld; H Schaller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

8.  Replication strategy of human hepatitis B virus.

Authors:  H Will; W Reiser; T Weimer; E Pfaff; M Büscher; R Sprengel; R Cattaneo; H Schaller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor.

Authors:  C Lüdin; H Hofstetter; M Sarfati; C A Levy; U Suter; D Alaimo; E Kilchherr; H Frost; G Delespesse
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

10.  Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line.

Authors:  C M Chang; K S Jeng; C P Hu; S J Lo; T S Su; L P Ting; C K Chou; S H Han; E Pfaff; J Salfeld
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.